Needle-Free Injection Systems: Growth Driven by Technology and Safety Concerns
The needle-free injection systems market is projected to reach USD 466.2 million by 2030, growing at a robust CAGR of 13.3%. This growth is driven by the rising global diabetic population, the increasing demand for self-injection devices, fear of needles, and the growing number of needlestick injuries.
Among product types, the prefilled category is expected to expand at the fastest rate, with a growth rate exceeding 14%. This can be attributed to the automation of most prefilled syringes, which reduces the risk of physical handling and ensures safer usage.